Cognetivity To Assist In Effective Delivery Of Recently Approved Alzheimer’s Drugs
Cognetivity Neurosciences (CSE: CGN) is set to benefit from a recent ruling by the Centers for Medicare and Medicaid Services,
Read moreCognetivity Neurosciences (CSE: CGN) is set to benefit from a recent ruling by the Centers for Medicare and Medicaid Services,
Read moreCognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new patent. The filing relates to
Read moreJoining us at the midpoint of the week on the Daily Dive, is that of Dr Thomas Sawyer, COO of
Read more